Statistics
Publications
4
Citations
563
H-Index
4
Active since
2020
Hui-Qi Dai is an author at Guangxi Medical University specializing in molecular oncology, oncology, and cancer pharmacology.
Publications per year
2020–2022
4
4
Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
Zhongjie Li, Hui-Qi Dai, Xiaowei Huang et al. · Acta Pharmacologica Sinica · 2020 · 308 citations · Full text
Medicine, Oncology, Pharmacology +12
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
Feng Ji, Peizhi Lu, Guangzhi Zhu et al. · Acta Pharmacologica Sinica · 2020 · 165 citations · Full text
Medicine, Cancer Biology, Oncology +16
1–4 of 4